InPoint Commercial Real Estate Income, Inc. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that InPoint Commercial Real Estate Income, Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $23.01M | Mar 13, 2026 |
| FY2025 | Dec 31, 2024 | $24.39M | Mar 13, 2026 |
| FY2025 | Dec 31, 2023 | $38.78M | Mar 13, 2026 |
| FY2024 | Dec 31, 2022 | $38.04M | Mar 14, 2025 |
| FY2023 | Dec 31, 2021 | $28.30M | Mar 15, 2024 |
| FY2022 | Dec 31, 2020 | $24.15M | Mar 30, 2023 |
| FY2021 | Dec 31, 2019 | $20.26M | Mar 11, 2022 |
| FY2020 | Dec 31, 2018 | $7.01M | Mar 19, 2021 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($1.57M) | Mar 13, 2026 |
| FY2025 | Dec 31, 2024 | $12.67M | Mar 13, 2026 |
| FY2025 | Dec 31, 2023 | ($4.44M) | Mar 13, 2026 |
| FY2024 | Dec 31, 2022 | $10.18M | Mar 14, 2025 |
| FY2023 | Dec 31, 2021 | $9.87M | Mar 15, 2024 |
| FY2022 | Dec 31, 2020 | ($28.78M) | Mar 30, 2023 |
| FY2021 | Dec 31, 2019 | $13.71M | Mar 11, 2022 |
| FY2020 | Dec 31, 2018 | $2.07M | Mar 19, 2021 |
| FY2019 | Dec 31, 2017 | $81.0K | Mar 11, 2020 |
| FY2018 | Dec 31, 2016 | ($31.0K) | Mar 12, 2019 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2019 | Dec 31, 2017 | $96.0K | Mar 11, 2020 |
| FY2018 | Dec 31, 2016 | $19.0K | Mar 12, 2019 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $11.39M | Mar 13, 2026 |
| FY2025 | Dec 31, 2024 | $17.98M | Mar 13, 2026 |
| FY2025 | Dec 31, 2023 | $16.20M | Mar 13, 2026 |
| FY2024 | Dec 31, 2022 | $18.52M | Mar 14, 2025 |
| FY2023 | Dec 31, 2021 | $11.64M | Mar 15, 2024 |
| FY2022 | Dec 31, 2020 | $12.00M | Mar 30, 2023 |
| FY2021 | Dec 31, 2019 | $10.08M | Mar 11, 2022 |
| FY2020 | Dec 31, 2018 | $3.23M | Mar 19, 2021 |
| FY2019 | Dec 31, 2017 | $307.0K | Mar 11, 2020 |
| FY2018 | Dec 31, 2016 | $10.0K | Mar 12, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $529.24M | Mar 13, 2026 |
| FY2025 | Dec 31, 2024 | $661.32M | Mar 13, 2026 |
| FY2024 | Dec 31, 2023 | $780.35M | Mar 14, 2025 |
| FY2023 | Dec 31, 2022 | $914.50M | Mar 15, 2024 |
| FY2022 | Dec 31, 2021 | $764.43M | Mar 30, 2023 |
| FY2021 | Dec 31, 2020 | $554.99M | Mar 11, 2022 |
| FY2020 | Dec 31, 2019 | $703.32M | Mar 19, 2021 |
| FY2019 | Dec 31, 2018 | $372.02M | Mar 11, 2020 |
| FY2018 | Dec 31, 2017 | $61.14M | Mar 12, 2019 |
| FY2017 | Dec 31, 2016 | $6.93M | Mar 14, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $302.99M | Mar 13, 2026 |
| FY2025 | Dec 31, 2024 | $416.74M | Mar 13, 2026 |
| FY2024 | Dec 31, 2023 | $529.79M | Mar 14, 2025 |
| FY2023 | Dec 31, 2022 | $635.94M | Mar 15, 2024 |
| FY2022 | Dec 31, 2021 | $457.28M | Mar 30, 2023 |
| FY2021 | Dec 31, 2020 | $314.74M | Mar 11, 2022 |
| FY2020 | Dec 31, 2019 | $447.15M | Mar 19, 2021 |
| FY2019 | Dec 31, 2018 | $229.75M | Mar 11, 2020 |
| FY2018 | Dec 31, 2017 | $19.16M | Mar 12, 2019 |
| FY2017 | Dec 31, 2016 | $1.05M | Mar 14, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $226.25M | Mar 13, 2026 |
| FY2025 | Dec 31, 2024 | $244.58M | Mar 13, 2026 |
| FY2025 | Dec 31, 2023 | $250.55M | Mar 13, 2026 |
| FY2025 | Dec 31, 2022 | $278.56M | Mar 13, 2026 |
| FY2024 | Dec 31, 2021 | $307.15M | Mar 14, 2025 |
| FY2023 | Dec 31, 2020 | $240.26M | Mar 15, 2024 |
| FY2022 | Dec 31, 2019 | $256.17M | Mar 30, 2023 |
| FY2021 | Dec 31, 2018 | $142.27M | Mar 11, 2022 |
| FY2020 | Dec 31, 2017 | $41.99M | Mar 19, 2021 |
| FY2019 | Dec 31, 2016 | $5.88M | Mar 11, 2020 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($115.12M) | Mar 13, 2026 |
| FY2025 | Dec 31, 2024 | ($94.96M) | Mar 13, 2026 |
| FY2024 | Dec 31, 2023 | ($89.04M) | Mar 14, 2025 |
| FY2023 | Dec 31, 2022 | ($60.93M) | Mar 15, 2024 |
| FY2022 | Dec 31, 2021 | ($52.28M) | Mar 30, 2023 |
| FY2021 | Dec 31, 2020 | ($47.25M) | Mar 11, 2022 |
| FY2020 | Dec 31, 2019 | ($9.81M) | Mar 19, 2021 |
| FY2019 | Dec 31, 2018 | ($6.38M) | Mar 11, 2020 |
| FY2018 | Dec 31, 2017 | ($1.45M) | Mar 12, 2019 |
| FY2017 | Dec 31, 2016 | ($64.2K) | Mar 14, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $76.56M | Mar 13, 2026 |
| FY2025 | Dec 31, 2024 | $64.55M | Mar 13, 2026 |
| FY2024 | Dec 31, 2023 | $54.14M | Mar 14, 2025 |
| FY2023 | Dec 31, 2022 | $29.41M | Mar 15, 2024 |
| FY2022 | Dec 31, 2021 | $57.27M | Mar 30, 2023 |
| FY2021 | Dec 31, 2020 | $72.11M | Mar 11, 2022 |
| FY2020 | Dec 31, 2019 | $37.21M | Mar 19, 2021 |
| FY2019 | Dec 31, 2018 | $27.53M | Mar 11, 2020 |
| FY2018 | Dec 31, 2017 | $1.31M | Mar 12, 2019 |
| FY2017 | Dec 31, 2016 | $511.9K | Mar 14, 2018 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Mar 13, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Mar 13, 2026 |
| FY2025 | Dec 31, 2023 | (1) | Mar 13, 2026 |
| FY2024 | Dec 31, 2022 | 0 | Mar 14, 2025 |
| FY2023 | Dec 31, 2021 | 0 | Mar 15, 2024 |
| FY2022 | Dec 31, 2020 | (2) | Mar 30, 2023 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Mar 13, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Mar 13, 2026 |
| FY2025 | Dec 31, 2023 | (1) | Mar 13, 2026 |
| FY2024 | Dec 31, 2022 | 0 | Mar 14, 2025 |
| FY2023 | Dec 31, 2021 | 0 | Mar 15, 2024 |
| FY2022 | Dec 31, 2020 | (2) | Mar 30, 2023 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2018 | Dec 31, 2018 | 5.94M | Mar 12, 2019 |
| FY2018 | Dec 31, 2017 | 1.73M | Mar 12, 2019 |
| FY2017 | Dec 31, 2016 | 237,700 | Mar 14, 2018 |
Dividends Paid
Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $12.61M | Mar 13, 2026 |
| FY2025 | Dec 31, 2024 | $12.60M | Mar 13, 2026 |
| FY2025 | Dec 31, 2023 | $12.51M | Mar 13, 2026 |
| FY2024 | Dec 31, 2022 | $12.45M | Mar 14, 2025 |
| FY2023 | Dec 31, 2021 | $12.39M | Mar 15, 2024 |
| FY2022 | Dec 31, 2020 | $9.25M | Mar 30, 2023 |
| FY2021 | Dec 31, 2019 | $16.33M | Mar 11, 2022 |
| FY2020 | Dec 31, 2018 | $6.33M | Mar 19, 2021 |
| FY2019 | Dec 31, 2017 | $1.24M | Mar 11, 2020 |